Astrocyte resilience to oxidative stress induced by insulin-like growth factor i (IGF-I) involves preserved AKT (protein kinase B) activity

Journal of Biological Chemistry

Volumn 291, Issue 5, 2016, Pages 2510-2523

  Dávila, David ^a   Fernández, Silvia ^a   Torres Alemán, Ignacio ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; CELL DEATH; CELL MEMBRANES; CHEMICAL ACTIVATION; CHEMICAL COMPOUNDS; ENZYMES; INSULIN; OXIDATIVE STRESS; PROTEINS;

CONSTITUTIVELY ACTIVES; CYTOPROTECTIVE EFFECTS; DEFENSE MECHANISM; INSULIN-LIKE GROWTH FACTOR-I; MOLECULAR MECHANISM; NEURODEGENERATION; OXIDATIVE CONDITIONS; PROTECTIVE ACTION;

NEURONS;

HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

EID: 84957006670     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.695478     Document Type: Article

References (70)

1. Torres Aleman, I. (2005) Role of insulin-like growth factors in neuronal plasticity and neuroprotection. Adv. Exp. Med. Biol. 567, 243-258
2. Zheng, W. H., Kar, S., Dore, S., and Quirion, R. (2000) Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway. J. Neural Transm. Suppl. 261-272
3. Datta, S. R., Brunet, A., and Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927
4. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., and Tonks, N. K. (1998) The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. U.S.A. 95, 13513-13518
5. Shepherd, P. R., Withers, D. J., and Siddle, K. (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 333, 471-490
6. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101
7. Dröge, W. (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95
8. Dringen, R., Pawlowski, P. G., and Hirrlinger, J. (2005) Peroxide detoxification by brain cells. J. Neurosci. Res. 79, 157-165
9. Dávila, D., and Torres-Aleman, I. (2008) Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. Mol. Biol. Cell 19, 2014-2025
10. Kwak, Y. D., Wang, B., Li, J. J., Wang, R., Deng, Q., Diao, S., Chen, Y., Xu, R., Masliah, E., Xu, H., Sung, J. J., and Liao, F. F. (2012) Upregulation of the E3 ligaseNEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration. J. Neurosci. 32, 10971-10981
11. Zhong, J., and Lee, W. H. (2007) Hydrogen peroxide attenuates insulinlike growth factor-1 neuroprotective effect, prevented by minocycline. Neurochem. Int. 51, 398-404
12. Yin, W., Park, J. I., and Loeser, R. F. (2009) Oxidative stress inhibits insulinlike growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-kinase-Akt and MEK-ERK MAPK signaling pathways. J. Biol. Chem. 284, 31972-31981
13. Braeckman, B. P., Houthoofd, K., and Vanfleteren, J. R. (2001) Insulin-like signaling, metabolism, stress resistance and aging in Caenorhabditis elegans. Mech. Ageing Dev. 122, 673-693
14. Broughton, S. J., Piper, M. D., Ikeya, T., Bass, T. M., Jacobson, J., Driege, Y., Martinez, P., Hafen, E., Withers, D. J., Leevers, S. J., and Partridge, L. (2005) Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc. Natl. Acad. Sci. U.S.A. 102, 3105-3110
15. Hinkal, G., and Donehower, L. A. (2008) How does suppression of IGF-1 signaling by DNA damage affect aging and longevity? Mech. Ageing Dev. 129, 243-253
16. Genis, L., Dávila, D., Fernandez, S., Pozo-Rodrigálvarez, A., Martínez-Murillo, R., and Torres-Aleman, I. (2014) Astrocytes require insulinlike growth factor I to protect neurons against oxidative injury. F1000Res. 3, 28
17. Ribeiro, M., Rosenstock, T. R., Oliveira, A. M., Oliveira, C. R., and Rego, A. C. (2014) Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells. Free Radic. Biol. Med. 74, 129-144
18. Grinberg, Y. Y., Dibbern, M. E., Levasseur, V. A., and Kraig, R. P. (2013) Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-β responses to spreading depression. J. Neurochem. 126, 662-672
19. Kooijman, R., Sarre, S., Michotte, Y., and De Keyser, J. (2009) Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? Stroke 40, e83-88
20. Torres-Aleman, I. (2007) Targeting insulin-like growth factor-1 to treat Alzheimer's disease. Expert Opin. Ther. Targets 11, 1535-1542
21. Fernandez-Fernandez, S., Almeida, A., and Bolaños, J. P. (2012) Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem. J. 443, 3-11
22. Gilley, J., Coffer, P. J., and Ham, J. (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol. 162, 613-622
23. Franco, C., Fernández, S., and Torres-Alemán, I. (2012) Frataxin deficiency unveils cell-context dependent actions of insulin-like growth factor I on neurons. Mol. Neurodegener. 7, 51
24. Finkel, T. (2003) Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254
25. Garcia-Galloway, E., Arango, C., Pons, S., and Torres-Aleman, I. (2003) Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling. Mol. Cell. Neurosci. 24, 1027-1037
26. Essafi, A., Gomes, A. R., Pomeranz, K. M., Zwolinska, A. K., Varshochi, R., McGovern, U. B., and Lam, E. W. (2009) Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt. Methods Mol. Biol. 462, 201-211
27. Vazquez, F., Ramaswamy, S., Nakamura, N., and Sellers, W. R. (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell. Biol. 20, 5010-5018
28. Fragoso, R., and Barata, J. T. (2015) Kinases, tails and more: regulation of PTEN function by phosphorylation. Methods 77-78, 75-81
29. Vazquez, F., Matsuoka, S., Sellers, W. R., Yanagida, T., Ueda, M., and Devreotes, P. N. (2006) Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 103, 3633-3638
30. Biggs, W. H., 3rd, Meisenhelder, J., Hunter, T., Cavenee, W. K., and Arden, K. C. (1999) Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. U.S.A. 96, 7421-7426
31. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead tran-scription factor. Cell 96, 857-868
32. Lehtinen, M. K., Yuan, Z., Boag, P. R., Yang, Y., Villén, J., Becker, E. B., DiBacco, S., de la Iglesia, N., Gygi, S., Blackwell, T. K., and Bonni, A. (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125, 987-1001
33. Linseman, D. A., Phelps, R. A., Bouchard, R. J., Le, S. S., Laessig, T. A., McClure, M. L., and Heidenreich, K. A. (2002) Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons. J. Neurosci. 22, 9287-9297
34. Park, H. S., Kim, M. S., Huh, S. H., Park, J., Chung, J., Kang, S. S., and Choi, E. J. (2002) Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J. Biol. Chem. 277, 2573-2578
35. Rojo, A. I., Salinas, M., Martín, D., Perona, R., and Cuadrado, A. (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-κB. J. Neurosci. 24, 7324-7334
36. Wang, L., Chen, Y., Sternberg, P., and Cai, J. (2008) Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Invest. Ophthalmol. Vis. Sci. 49, 1671-1678
37. Hemi, R., Yochananov, Y., Barhod, E., Kasher-Meron, M., Karasik, A., Tirosh, A., and Kanety, H. (2011) p38 mitogen-activated protein kinasedependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Diabetes 60, 1134-1145
38. Diamond-Stanic, M. K., Marchionne, E. M., Teachey, M. K., Durazo, D. E., Kim, J. S., and Henriksen, E. J. (2011) Critical role of the transient activation of p38 MAPK in the etiology of skeletal muscle insulin resistance induced by low-level in vitro oxidant stress. Biochem. Biophys. Res. Commun. 405, 439-444
39. Wu, Y., Song, P., Zhang, W., Liu, J., Dai, X., Liu, Z., Lu, Q., Ouyang, C., Xie, Z., Zhao, Z., Zhuo, X., Viollet, B., Foretz, M., Wu, J., Yuan, Z., and Zou, M. H. (2015) Activation ofAMPKα2 in adipocytes is essential for nicotineinduced insulin resistance in vivo. Nat. Med. 21, 373-382
40. Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B., and Rondinone, C. M. (2003) Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52, 634-641
41. Kumphune, S., Chattipakorn, S., and Chattipakorn, N. (2013) Roles of p38-MAPK in insulin resistant heart: evidence from bench to future bedside application. Curr. Pharm. Des. 19, 5742-5754
42. Qi, Y., Xu, Z., Zhu, Q., Thomas, C., Kumar, R., Feng, H., Dostal, D. E., White, M. F., Baker, K. M., and Guo, S. (2013) Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance. Diabetes 62, 3887-3900
43. Park, S. B., Jung, W. H., Kang, N. S., Park, J. S., Bae, G. H., Kim, H. Y., Rhee, S. D., Kang, S. K., Ahn, J. H., Jeong, H. G., and Kim, K. Y. (2013) Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice. Eur. J. Pharmacol. 721, 70-79
44. Hernandez, R., Teruel, T., de Alvaro, C., and Lorenzo, M. (2004) Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-β induction of p38 and p42/p44 mitogen-activated protein kinases. Diabetologia 47, 1615-1624
45. Bloch-Damti, A., and Bashan, N. (2005) Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox Signal. 7, 1553-1567
46. Shin, J. H., Jeong, J. Y., Jin, Y., Kim, I. D., and Lee, J. K. (2011) p38beta MAPK affords cytoprotection against oxidative stress-induced astrocyte apoptosis via induction of αB-crystallin and its anti-apoptotic function. Neurosci. Lett. 501, 132-137
47. Pramanik, R., Qi, X., Borowicz, S., Choubey, D., Schultz, R. M., Han, J., and Chen, G. (2003) p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J. Biol. Chem. 278, 4831-4839
48. Zhou, X., Ferraris, J. D., Dmitrieva, N. I., Liu, Y., and Burg, M. B. (2008) MKP-1 inhibits high NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: opposite roles of p38α and p38δ. Proc. Natl. Acad. Sci. U.S.A. 105, 5620-5625
49. Cuadrado, A., and Nebreda, A. R. (2010) Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417
50. Bolduc, D., Rahdar, M., Tu-Sekine, B., Sivakumaren, S. C., Raben, D., Amzel, L. M., Devreotes, P., Gabelli, S. B., and Cole, P. (2013) Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis. eLife 2, e00691
51. Pinna, L. A. (2002) Protein kinase CK2: a challenge to canons. J. Cell Sci. 115, 3873-3878
52. Ahmed, K., Gerber, D. A., and Cochet, C. (2002) Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12, 226-230
53. Torres, J., and Pulido, R. (2001) The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993-998
54. Fernández, S., García-García, M., and Torres-Alemán, I. (2008) Modulation by insulin-like growth factor I of the phosphatase PTEN in astrocytes. Biochim. Biophys. Acta 1783, 803-812
55. Vargas, M. R., Pehar, M., Cassina, P., Estévez, A. G., Beckman, J. S., and Barbeito, L. (2004) Stimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo 18, 269-274
56. Tanaka, J., Toku, K., Zhang, B., Ishihara, K., Sakanaka, M., and Maeda, N. (1999) Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28, 85-96
57. Cassina, P., Cassina, A., Pehar, M., Castellanos, R., Gandelman, M., de León, A., Robinson, K. M., Mason, R. P., Beckman, J. S., Barbeito, L., and Radi, R. (2008) Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J. Neurosci. 28, 4115-4122
58. Da Silva, C. A., Heilbock, C., Kassel, O., and Frossard, N. (2003) Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin-1beta through concerted regulation of a GRE-like and an NF-κB response element. FASEB J. 17, 2334-2336
59. Han, Z. B., Ren, H., Zhao, H., Chi, Y., Chen, K., Zhou, B., Liu, Y. J., Zhang, L., Xu, B., Liu, B., Yang, R., and Han, Z. C. (2008) Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 29, 1853-1861
60. Butler, M., McKay, R. A., Popoff, I. J., Gaarde, W. A., Witchell, D., Murray, S. F., Dean, N. M., Bhanot, S., and Monia, B. P. (2002) Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51, 1028-1034
61. Hu, Z., Wang, H., Lee, I. H., Modi, S., Wang, X., Du, J., and Mitch, W. E. (2010) PTEN inhibition improves muscle regeneration in mice fed a highfat diet. Diabetes 59, 1312-1320
62. Oudit, G. Y., Kassiri, Z., Zhou, J., Liu, Q. C., Liu, P. P., Backx, P. H., Dawood, F., Crackower, M. A., Scholey, J. W., and Penninger, J. M. (2008) Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc. Res. 78, 505-514
63. Keyes, K. T., Xu, J., Long, B., Zhang, C., Hu, Z., and Ye, Y. (2010) Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am. J. Physiol. Heart Circ. Physiol. 298, H1198-H1208
64. Li, W., Huang, R., Chen, Z., Yan, L. J., Simpkins, J. W., and Yang, S. H. (2014) PTEN degradation after ischemic stroke: a double-edged sword. Neuroscience 274, 153-161
65. Mao, L., Jia, J., Zhou, X., Xiao, Y., Wang, Y., Mao, X., Zhen, X., Guan, Y., Alkayed, N. J., and Cheng, J. (2013) Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke. Neuroscience 231, 272-281
66. Sperow, M., Berry, R. B., Bayazitov, I. T., Zhu, G., Baker, S. J., and Zakharenko, S. S. (2012) Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration. J. Physiol. 590, 777-792
67. Endersby, R., and Baker, S. J. (2008) PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27, 5416-5430
68. Cho, J., Lee, S. H., Seo, J. H., Kim, H. S., Ahn, J. G., Kim, S. S., Yim, S. V., Song, D. K., and Cho, S. S. (2002) Increased expression of phosphatase and tensin homolog in reactive astrogliosis following intracerebroventricular kainic acid injection in mouse hippocampus. Neurosci. Lett. 334, 131-134
69. Christie, K. J., Webber, C. A., Martinez, J. A., Singh, B., and Zochodne, D. W. (2010) PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J. Neurosci. 30, 9306-9315
70. Liu, X., Yao, D. L., Bondy, C. A., Brenner, M., Hudson, L. D., Zhou, J., and Webster, H. D. (1994) Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol. Cell. Neurosci. 5, 418-430